Nightshift work and risk of breast cancer and other cancers-A critical review of the epidemiologic evidence

Scandinavian Journal of Work, Environment and Health, Supplement

Volumn 34, Issue 1, 2008, Pages 5-22

  Kolstad, Henrik A ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Chronobiology disorder; Circadian rhythm; Occupational exposure; Occupational health; Shift work

Indexed keywords

ALCOHOL; MELATONIN; ORAL CONTRACEPTIVE AGENT; 6 HYDROXYMELATONIN O SULFATE;

ALCOHOL CONSUMPTION; BREAST CANCER; CANCER RISK; CIRCADIAN RHYTHM; COLON CANCER; DISEASE ASSOCIATION; EXERCISE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MENARCHE; NIGHT WORK; NURSE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SHIFT WORKER; SYSTEMATIC REVIEW; WORK SCHEDULE; WORKING TIME; BEHAVIOR; CANCER EPIDEMIOLOGY; CAUSAL ATTRIBUTION; CONFOUNDING VARIABLE; JOB STRESS; LIGHT EXPOSURE; NONHUMAN; OCCUPATIONAL CANCER; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PREVALENCE; RISK FACTOR; SLEEP DEPRIVATION; SYSTEMATIC ERROR; URINE LEVEL; VISUAL IMPAIRMENT;

CANCER; CIRCADIAN RHYTHM; HEALTH RISK; OCCUPATIONAL EXPOSURE; RISK ASSESSMENT;

EURASIA; EUROPE; NORTHERN EUROPE; SCANDINAVIA;

EID: 42549132426     PISSN: 03566528     EISSN: None     Source Type: Journal    
DOI: 10.5271/sjweh.1194     Document Type: Review

References (109)

1. Stevens RG. Electric power use and breast cancer: A hypothesis. Am J Epidemiol. 1987;125:556-61.
2. Stevens RG. Artificial lighting in the industrialized world: circadian disruption and breast cancer. Cancer Causes Control. 2006;17:501-7.
3. Megdal SP, Kroenke CH, Laden F, Pukkala E, Schernhammer ES. Night work and breast cancer risk: A systematic review and meta-Analysis. Eur J Cancer. 2005;41:2023-32.
4. Taylor PJ, Pocock SJ. Mortality of shift and day workers 1956-68. Br J Ind Med. 1972;29:201-7.
5. Rafnsson V, Gunnarsdottir H. Mortality study of fertiliser manufacturers in Iceland. Br J Ind Med. 1990;47:721-5.
6. O'Leary ES, Schoenfeld ER, Stevens RG, Kabat GC, Henderson K, Grimson R, et al. Shift work, light at night, and breast cancer on Long Island, New York. Am J Epidemiol. 2006;164:358-66.
7. Kubo T, Ozasa K, Mikami K, Wakai K, Fujino Y, Watanabe Y, et al. Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan collaborative cohort study. Am J Epidemiol. 2006;164:549-55.
8. Conlon M, Lightfoot N, Kreiger N. Rotating shift work and risk of prostate cancer. Epidemiology. 2007;18:182-3.
9. Schwartzbaum J, Ahlbom A, Feychting M. Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health. 2007;33(5):336-43.
10. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18:581-92.
11. Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst. 1995;87:1681-5.
12. Sasco AJ, Kaaks R, Little RE. Breast cancer: occurrence, risk factors and hormone metabolism. Expert Rev Anticancer Ther. 2003;3:546-62.
13. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med. 2006;354:270-82.
14. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet. 1996;347:1713-27.
15. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52, 705 women with breast cancer and 108, 411 women without breast cancer. Lancet. 1997;350:1047-59.
16. Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW Jr, et al. Alcohol, tobacco and breast cancer-collaborative reanalysis of individual data from 53 epidemiological studies, including 58, 515 women with breast cancer and 95, 067 women without the disease. Br J Cancer. 2002;87:1234-45.
17. Krebs EE, Taylor BC, Cauley JA, Stone KL, Bowman PJ, Ensrud KE. Measures of adiposity and risk of breast cancer in older postmenopausal women. J Am Geriatr Soc. 2006;54:63-9.
18. European Foundation for the Improvement of living and Working Conditions. Fourth European Working Conditions Survey. Luxembourg: Office for Official Publications of the European Communities; 2007.
19. European Foundation for the Improvement of living and Working Conditions. Third European survey on working conditions 2000. Luxembourg: Office for Official Publications of the European Communities; 2001.
20. Figueiro MG, Rea MS, Bullough JD. Does architectural lighting contribute to breast cancer? J Carcinog. 2006;5:20.
21. Bøggild H, Knutsson A. Shift work, risk factors and cardiovascular disease [review]. Scand J Work Environ Health. 1999;25(2):85-99.
22. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst. 2001;93:1563-8.
23. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst. 2003;95:825-8.
24. Schernhammer ES, Kroenke CH, Laden F, Hankinson SE. Night work and risk of breast cancer. Epidemiology. 2006;17:108-11.
25. Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology. 2001;12:74-7.
26. Ingre M, Akerstedt T. Effect of accumulated night work during the working lifetime, on subjective health and sleep in monozygotic twins. J Sleep Res. 2004;13:45-8.
27. Knutsson A. Methodological aspects of shift-work research. Chronobiol Int. 2004;21:1037-47.
28. Härmä M. Workhours in relation to work stress, recovery and health [review]. Scand J Work Environ Health. 2006;32(6, special issue):502-14.
29. Hansen AM, Garde AH, Hansen J. Diurnal urinary 6-sulfatoxymelatonin levels among healthy Danish nurses during work and leisure time. Chronobiol Int. 2006;23:1203-15.
30. Borugian MJ, Gallagher RP, Friesen MC, Switzer TF, Aronson KJ. Twenty-four-hour light exposure and melatonin levels among shift workers. J Occup Environ Med. 2005;47:1268-75.
31. Schernhammer ES, Rosner B, Willett WC, Laden F, Colditz GA, Hankinson SE. Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev. 2004;13:936-43.
32. Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst. 2001;93:1557-62.
33. Tynes T, Hannevik M, Andersen A, Vistnes AI, Haldorsen T. Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control. 1996;7:197-204.
34. Lie JA, Roessink J, Kjaerheim K. Breast cancer and night work among Norwegian nurses. Cancer Causes Control. 2006;17:39-44.
35. Anisimov VN. The light-dark regimen and cancer development. Neuro Endocrinol Lett. 2002;23 suppl2:28-36.
36. Anisimov VN. The role of pineal gland in breast cancer development. Crit Rev Oncol Hematol. 2003;46:221-34.
37. Anisimov VN. Light pollution, reproductive function and cancer risk. Neuro Endocrinol Lett. 2006;27:35-52.
38. Anisimov VN, Vinogradova IA. Light-dark conditions, melatonin and risk of cancer. Vopr Onkol. 2006;52:491-8.
39. Blask DE, Dauchy RT, Sauer LA. Putting cancer to sleep at night: The neuroendocrine/circadian melatonin signal. Endocrine. 2005;27:179-88.
40. Bullough JD, Rea MS, Figueiro MG. Of mice and women: light as a circadian stimulus in breast cancer research. Cancer Causes Control. 2006;17:375-83.
41. Cornelissen G, Halberg F. Chronobiologic response modifiers and breast cancer development: classical background and chronobiologic tasks remaining. In Vivo. 1992;6:387-402.
42. Coyle YM. The effect of environment on breast cancer risk. Breast Cancer Res Treat. 2004;84:273-88.
43. Davis S, Mirick DK. Circadian disruption, shift work and the risk of cancer: A summary of the evidence and studies in Seattle. Cancer Causes Control. 2006;17:539-45.
44. Feychting M, Ahlbom A. Kan ljusexponering påverka risken för bröstcancer [Can light exposure affect the risk of breast cancer?: female flight attendants and shift-workers probably the most vulnerable groups]. Läkartidningen. 2001;98:4316-8.
45. Hansen J. Risk of breast cancer after night-And shift work: current evidence and ongoing studies in Denmark. Cancer Causes Control. 2006;17:531-7.
46. Haus E, Smolensky M. Biological clocks and shift work: circadian dysregulation and potential long-Term effects. Cancer Causes Control. 2006;17:489-500.
47. Jasser SA, Blask DE, Brainard GC. Light during darkness and cancer: Relationships in circadian photoreception and tumor biology. Cancer Causes Control. 2006;17:515-23.
48. Kenny C. Breast cancer: night shifts put nurses at risk. Nurs Times. 2001;97:9.
49. Kheifets LI, Matkin CC. Industrialization, electromagnetic fields, and breast cancer risk. Environ Health Perspect. 1999;107 suppl1:145-54.
50. Patel D. Shift work, light at night and risk of breast cancer. Occup Med (Lond). 2006;56:433.
51. Pauley SM. Lighting for the human circadian clock: Recent research indicates that lighting has become a public health issue. Med Hypotheses. 2004;63:588-96.
52. Schernhammer E, Schulmeister K. Light at night and cancer risk. Photochem Photobiol. 2004;79:316-8.
53. Schernhammer ES, Schulmeister K. Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels? Br J Cancer. 2004;90:941-3.
54. Stevens RG. Lighting during the day and night: possible impact on risk of breast cancer. Neuro Endocrinol Lett. 2002;23 suppl2:57-60.
55. Stevens RG. Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology. 2005;16:254-8.
56. Stevens RG, Rea MS. Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control. 2001;12:279-87.
57. Bonde JP, Andersen JH, Frost P, Kaergaard A, Kolstad HA, Thulstrup AM. Helbredsundersøgelse ved natarbejde [Health examinations in connection with night work]. Ugeskr Laeger. 2007;169:2005-7.
58. Frentzel-Beyme R. The melatonin hypothesis: A matter of method. Environ Health Perspect. 2002;110:A72-A73.
59. Hrushesky WJ, Blask DE. Re: Melatonin and breast cancer: A prospective study. J Natl Cancer Inst. 2004;96:888-9.
60. Kerenyi N. Re: Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst. 2002;94:531-2.
61. Porock D, Gentry J. Re: Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst. 2002;94:530-1.
62. Spiegel D, Sephton S. Re: Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst. 2002;94:530-3.
63. Tarone RE. Circadian disruption and breast cancer. Epidemiology. 2005;16:710-1.
64. Hansen J. Light at night, shiftwork, and breast cancer risk. J Natl Cancer Inst. 2001;93:1513-5.
65. Poole C. The darkness at the end of the tunnel: summary and evaluation of an international symposium on light, endocrine systems and cancer. Neuro Endocrinol Lett. 2002;23 suppl2:71-8.
66. Roenneberg T, Lucas RJ. Light, endocrine systems, and cancer-A view from circadian biologists. Neuro Endocrinol Lett. 2002;23 suppl2:82-3.
67. Night shifts and colorectal cancer risk. Mayo Clin Health Lett. 2005;23:4.
68. Kojo K, Pukkala E, Auvinen A. Breast cancer risk among Finnish cabin attendants: A nested case-control study. Occup Environ Med. 2005;62:488-93.
69. Rafnsson V, Hrafnkelsson J, Tulinius H. Incidence of cancer among commercial airline pilots. Occup Environ Med. 2000;57:175-9.
70. Rafnsson V, Tulinius H, Jonasson JG, Hrafnkelsson J. Risk of breast cancer in female flight attendants: A population-based study (Iceland). Cancer Causes Control. 2001;12:95-101.
71. Gurwitz D. Flight attendants, breast cancer, and melatonin. Lancet. 1998;352:1389-90.
72. Mawson AR. Breast cancer in female flight attendants. Lancet. 1998;352:626.
73. Radon K, Aberl S, Nowak D, Volkenandt M, Przybilla BJ, Siebeck M, et al. Incidence of cancer among commercial airline pilots. Occup Environ Med. 2000;57:843.
74. Cook MR, Graham C, Kavet R, Stevens RG, Davis S, Kheifets L. Morning urinary assessment of nocturnal melatonin secretion in older women. J Pineal Res. 2000;28:41-7.
75. Davis S, Kaune WT, Mirick DK, Chen C, Stevens RG. Residential magnetic fields, light-At-night, and nocturnal urinary 6- sulfatoxymelatonin concentration in women. Am J Epidemiol. 2001;154:591-600.
76. Schernhammer ES, Hankinson SE. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst. 2005;20;97:1084-7.
77. Schernhammer ES, Kroenke CH, Dowsett M, Folkerd E, Hankinson SE. Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels. J Pineal Res. 2006;40:116-24.
78. Stevens RG, Schernhammer E. Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev. 2005;14:551.
79. Zhu Y, Zheng T, Stevens RG, Zhang Y, Boyle P. Does "clock" matter in prostate cancer? Cancer Epidemiol Biomarkers Prev. 2006;15:3-5.
80. Gammon MD, Neugut AI, Santella RM, Teitelbaum SL, Britton JA, Terry MB, et al. The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat. 2002;74:235-54.
81. Pukkala E, Aspholm R, Auvinen A, Eliasch H, Gundestrup M, Haldorsen T, et al. Incidence of cancer among Nordic airline pilots over five decades: occupational cohort study. BMJ. 2002;325:567.
82. Zeeb H, Blettner M, Langner I, Hammer GP, Ballard TJ, Santaquilani M, et al. Mortality from cancer and other causes among airline cabin attendants in Europe: A collaborative cohort study in eight countries. Am J Epidemiol. 2003;158:35-46.
83. Rafnsson V, Sulem P, Tulinius H, Hrafnkelsson J. Breast cancer risk in airline cabin attendants: A nested case-control study in Iceland. Occup Environ Med. 2003;60:807-9.
84. Pukkala E, Ojamo M, Rudanko SL, Stevens RG, Verkasalo PK. Does incidence of breast cancer and prostate cancer decrease with increasing degree of visual impairment. Cancer Causes Control. 2006;17:573-6.
85. Sack RL, Lewy AJ, Blood ML, Keith LD, Nakagawa H. Circadian rhythm abnormalities in totally blind people: incidence and clinical significance. J Clin Endocrinol Metab. 1992;75:127-34.
86. Lockley SW, Skene DJ, Arendt J, Tabandeh H, Bird AC, Defrance R. Relationship between melatonin rhythms and visual loss in the blind. J Clin Endocrinol Metab. 1997;82:3763-70.
87. Klerman EB, Zeitzer JM, Duffy JF, Khalsa SB, Czeisler CA. Absence of an increase in the duration of the circadian melatonin secretory episode in totally blind human subjects. J Clin Endocrinol Metab. 2001;86:3166-70.
88. Travis RC, Allen DS, Fentiman IS, Key TJ. Melatonin and breast cancer: A prospective study. J Natl Cancer Inst. 2004;96:475-82.
89. Blask DE, Brainard GC, Dauchy RT, Hanifin JP, Davidson LK, Krause JA, et al. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res. 2005;65:11174-84.
90. Sanchez-Barcelo EJ, Cos S, Fernandez R, Mediavilla MD. Melatonin and mammary cancer: A short review. Endocr Relat Cancer. 2003;10:153-9.
91. Anderson LE, Morris JE, Sasser LB, Stevens RG. Effect of constant light on DMBA mammary tumorigenesis in rats. Cancer Lett. 2000;148:121-6.
92. Barnes RG, Deacon SJ, Forbes MJ, Arendt J. Adaptation of the 6-sulphatoxymelatonin rhythm in shiftworkers on offshore oil installations during a 2-week 12-h night shift. Neurosci Lett. 1998;241:9-12.
93. Margolese RG, Hortobagyi GN, Buchholz TA. Neoplasms of the breast. In: Kufe DW, Pollock RE, Weicheslbaum RR, Bast RC, Gansler TS, Holland JF, et al, editors. Cancer Medicine. Hamilton (Ontario): BC Decker Inc; 2003:1879-970.
94. Colditz GA. The nurses' health study: A cohort of US women followed since 1976. J Am Med Womens Assoc. 1995;50:40-4.
95. Gunnarsdottir H, Rafnsson V. Cancer incidence among Icelandic nurses. J Occup Environ Med. 1995;37:307-12.
96. Morton WE. Major differences in breast cancer risks among occupations. J Occup Environ Med. 1995;37:328-35.
97. Petralia SA, Chow WH, McLaughlin J, Jin F, Gao YT, Dosemeci M. Occupational risk factors for breast cancer among women in Shanghai. Am J Ind Med. 1998;34:477-83.
98. Peipins LA, Burnett C, Alterman T, Lalich N. Mortality patterns among female nurses: A 27-state study, 1984 through 1990. Am J Public Health. 1997;87:1539-43.
99. Andersen A, Barlow L, Engeland A, Kjærheim K, Lynge E, Pukkala E. Work-related cancer in the Nordic countries. Scand J Work Environ Health. 1999;25 suppl2:1-116.
100. Lie JA, Andersen A, Kjærheim K. Cancer risk among 43 000 Norwegian nurses. Scand J Work Environ Health. 2007;33(1):66-73.
101. MacArthur AC, Le ND, Abanto ZU, Gallagher RP. Occupational female breast and reproductive cancer mortality in British Columbia, Canada, 1950-94. Occup Med (Lond). 2007;57:246-53.
102. Habel LA, Stanford JL, Vaughan TL, Rossing MA, Voigt LF, Weiss NS, et al. Occupation and breast cancer risk in middleaged women. J Occup Environ Med. 1995;37:349-56.
103. Coogan PF, Clapp RW, Newcomb PA, Mittendorf R, Bogdan G, Baron JA, et al. Variation in female breast cancer risk by occupation. Am J Ind Med. 1996;30:430-7.
104. Band PR, Le ND, Fang R, Deschamps M, Gallagher RP, Yang P. Identification of occupational cancer risks in British Columbia: A population-based case-control study of 995 incident breast cancer cases by menopausal status, controlling for confounding factors. J Occup Environ Med. 2000;42:284-310.
105. Lie JA, Kjaerheim K. Cancer risk among female nurses: A literature review. Eur J Cancer Prev. 2003;12:517-26.
106. Petralia SA, Vena JE, Freudenheim JL, Michalek A, Goldberg MS, Blair A, et al. Risk of premenopausal breast cancer and patterns of established breast cancer risk factors among teachers and nurses. Am J Ind Med. 1999;35:137-41.
107. Swerdlow, A. Shift work and breast cancer; a critical review of the epidemiological evidence. Norwich (United Kingdom): Health and Safety Executive; 2003.
108. Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, et al. Carcinogenicity of shift-work, painting, and firefighting. Lancet Oncol. 2007;8:1065-6.
109. Stevens RG, Blask DE, Brainard GC, Hansen J, Lockley SW, Provencio I, et al. Meeting report: The role of environmental lighting and circadian disruption in cancer and other diseases. Environ Health Perspect. 2007;115:1357-62.